跳至主要内容
临床试验/ACTRN12611001275954
ACTRN12611001275954已完成未知

In infants <33 weeks gestation, does higher protein human milk fortifier compared to standard protein human milk fortifier improve weight gain?

Women's and Children's Hospital0 个研究点目标入组 60 人开始时间: 2011年12月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
28 Weeks 至 32 Weeks(—)
性别
All

入选标准

  • Infants <33 completed weeks gestation whose mothers intend to provide breast milk and have the written informed consent of their parents/guardians.

排除标准

  • Infants with major congenital or chromosomal abnormalities known to affect growth or where protein therapy is contraindicated e.g. major heart defects, cystic fibrosis, phenylketonuria, disorders of the urea cycle. Infants likely to transfer to remote locations where weekly blood tests are unable to be performed.

研究者

发起方
Women's and Children's Hospital

相似试验